1. SeneeV, ChelalaC, DuchateletS, FengD, BlancH, et al. (2006) Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 38: 682–687.
2. DimitriP, WarnerJT, MintonJA, PatchAM, EllardS, et al. (2011) Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol 164: 437–443.
3. BarrettJC, ConcannonP, AkolkarB, CooperJD, ErlichHA, et al. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703–707.
4. DupuisJ, ProkopenkoI, SaxenaR, SoranzoN, JacksonAU, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.
5. BoesgaardTW, GrarupN, JorgensenT, Borch-JohnsenK, HansenT, et al. (2010) Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated β-cell function in middle-aged Danish people. Diabetologia 53: 1647–1655.
6. LiH, GanW, LuL, DongX, HanX, et al. (2012) A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans. Diabetes 62: 291–298.
7. ChoYS, HuC, LongJ, OngRT, SimX, et al. (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44: 67–72.
8. BarkerA, SharpSJ, TimpsonNJ, Bouatia-NajiN, WarringtonNM, et al. (2011) Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 60: 1805–1812.
9. Kang HSKY, ZeRuthG, BeakJY, GerrishK, KilicG, et al. (2009) Transcription factor Glis3, a novel critical player in the regulation of pancreatic β-cell development and insulin gene expression. Mol Cell Biol 29: 6366–6379.
10. WatanabeNHK, MiyamotoR, YasudaK, SuzukiN, OshimaN, et al. (2009) A murine model of neonatal diabetes mellitus in Glis3-deficient mice. FEBS Lett 583: 2108–2113.
11. YangY, ChangBH, ChanL (2012) Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults. EMBO Mol Med 5: 92–104.
12. YangY, ChangBH, SamsonSL, LiMV, ChanL (2009) The Kruppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res 37: 2529–2538.
13. CnopM, WelshN, JonasJC, JornsA, LenzenS, et al. (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2): S97–107.
14. EizirikDL, ColliML, OrtisF (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219–226.
15. AhlqvistE, AhluwaliaTS, GroopL (2011) Genetics of type 2 diabetes. Clin Chem 57: 241–254.
16. McCarthyMI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339–2350.
17. VoightBF, ScottLJ, SteinthorsdottirV, MorrisAP, DinaC, et al. (2012) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579–589.
18. MooreF, ColliML, CnopM, EsteveMI, CardozoAK, et al. (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ-induced pancreatic β-cell apoptosis. Diabetes 58: 1283–1291.
19. ColliML, MooreF, GurzovEN, OrtisF, EizirikDL (2010) MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 19: 135–146.
20. SantinI, MooreF, ColliML, GurzovEN, MarselliL, et al. (2011) PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60: 3279–3288.
21. EizirikDL, SammethM, BouckenoogheT, BottuG, SisinoG, et al. (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8: e1002552 doi:10.1371/journal.pgen.1002552.
22. BergholdtR, BrorssonC, PallejaA, BerchtoldLA, FloyelT, et al. (2012) Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61: 954–962.
23. ColliML, NogueiraTC, AllagnatF, CunhaDA, GurzovEN, et al. (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic β-cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog 7: e1002267 doi:10.1371/journal.ppat.1002267.
24. CardozoAK, OrtisF, StorlingJ, FengYM, RasschaertJ, et al. (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54: 452–461.
25. AllagnatF, FukayaM, NogueiraTC, DelarocheD, WelshN, et al. (2012) C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. Cell Death Differ 19: 1836–1846.
26. EizirikDL, CnopM (2010) ER stress in pancreatic β-cells: the thin red line between adaptation and failure. Sci Signal 3: pe7.
27. GurzovEN, EizirikDL (2011) Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction. Trends Cell Biol 21: 424–431.
28. GurzovEN, OrtisF, CunhaDA, GossetG, LiM, et al. (2009) Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 16: 1539–1550.
29. GurzovEN, GermanoCM, CunhaDA, OrtisF, VanderwindenJM, et al. (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285: 19910–19920.
30. BarthsonJ, GermanoCM, MooreF, MaidaA, DruckerDJ, et al. (2011) Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 286: 39632–39643.
31. MooreF, SantinI, NogueiraTC, GurzovEN, MarselliL, et al. (2012) The transcription factor C/EBPδ has anti-apoptotic and anti-inflammatory roles in pancreatic β-cells. PLoS ONE 7: e31062 doi:10.1371/journal.pone.0031062.
32. O'ConnorL, StrasserA, O'ReillyLA, HausmannG, AdamsJM, et al. (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J 17: 384–395.
33. CunhaDA, GurzovEN, GermanoCM, NaamaneN, MarhfourI, et al. (2012) DP5 and PUMA mediate the ER stress-mitochondrial dialog triggering lipotoxic β-cell apoptosis. Diabetes 61: 2763–2775.
34. LeuS, LinYM, WuCH, OuyangP (2012) Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD. J Cell Sci 125: 3164–3172.
35. JiangCC, LaiF, TayKH, CroftA, RizosH, et al. (2010) Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis 1: e69.
36. FerdaoussiM, AbdelliS, YangJY, CornuM, NiederhauserG, et al. (2008) Exendin-4 protects β -cells from interleukin-1 β-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 57: 1205–1215.
37. CunhaDA, LadriereL, OrtisF, Igoillo-EsteveM, GurzovEN, et al. (2009) Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58: 2851–2862.
38. ButeauJ, El-AssaadW, RhodesCJ, RosenbergL, JolyE, et al. (2004) Glucagon-like peptide-1 prevents β-cell glucolipotoxicity. Diabetologia 47: 806–815.
39. KwonG, PappanKL, MarshallCA, SchafferJE, McDanielML (2004) cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in β-cells. J Biol Chem 279: 8938–8945.
40. RajSM, HowsonJM, WalkerNM, CooperJD, SmythDJ, et al. (2009) No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 52: 2109–2116.
41. OwenKR, McCarthyMI (2009) Type 1 and type 2 diabetes-chalk and cheese? Diabetologia 52: 1983–1986.
42. WinklerC, RaabJ, GrallertH, ZieglerAG (2012) Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes. PLoS ONE 7: e35410 doi:10.1371/journal.pone.0035410.
43. CervinC, LyssenkoV, BakhtadzeE, LindholmE, NilssonP, et al. (2008) Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57: 1433–1437.
44. MorrisAP, VoightBF, TeslovichTM, FerreiraT, SegrèAV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981–990.
45. MarselliL, ThorneJ, DahiyaS, SgroiDC, SharmaA, et al. (2010) Gene expression profiles of β-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS ONE 5: e11499 doi:10.1371/journal.pone.0011499.
46. TaneeraJ, LangS, SharmaA, FadistaJ, ZhouY, et al. (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. . Cell Metab 16: 122–134.
47. FujimotoK, ChenY, PolonskyKS, DornGW2nd (2010) Targeting cyclophilin D and the mitochondrial permeability transition enhances β-cell survival and prevents diabetes in Pdx1 deficiency. Proc Natl Acad Sci U S A 107: 10214–10219.
48. SachdevaMM, ClaibornKC, KhooC, YangJ, GroffDN, et al. (2009) Pdx1 (MODY4) regulates pancreatic β-cell susceptibility to ER stress. Proc Natl Acad Sci U S A 106: 19090–19095.
49. LeyR, EwingsKE, HadfieldK, CookSJ (2005) Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12: 1008–1014.
50. WeberA, PaschenSA, HegerK, WilflingF, FrankenbergT, et al. (2007) BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 177: 625–636.
51. ChenL, WillisSN, WeiA, SmithBJ, FletcherJI, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393–403.
52. McKenzieMD, JamiesonE, JansenES, ScottCL, HuangDC, et al. (2010) Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 59: 644–652.
53. MooreF, NaamaneN, ColliML, BouckenoogheT, OrtisF, et al. (2011) STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation. J Biol Chem 286: 929–941.
54. PuthalakathH, HuangDC, O'ReillyLA, KingSM, StrasserA (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287–296.
55. PanQ, ShaiO, LeeLJ, FreyBJ, BlencoweBJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413–1415.
56. EvsyukovaI, SomarelliJA, GregorySG, Garcia-BlancoMA (2010) Alternative splicing in multiple sclerosis and other autoimmune diseases. RNA Biol 7: 462–473.
57. OrtisF, NaamaneN, FlamezD, LadriereL, MooreF, et al. (2010) Cytokines interleukin-1β and tumor necrosis factor-α regulate different transcriptional and alternative splicing networks in primary β-cells. Diabetes 59: 358–374.
58. PipeleersDG, in't VeldPA, Van de WinkelM, MaesE, SchuitFC, et al. (1985) A new in vitro model for the study of pancreatic α and β cells. Endocrinology 117: 806–816.
59. RasschaertJ, LadriereL, UrbainM, DogusanZ, KatabuaB, et al. (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280: 33984–33991.
60. LupiR, DottaF, MarselliL, Del GuerraS, MasiniM, et al. (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51: 1437–1442.
61. MooreF, CunhaDA, MulderH, EizirikDL (2012) Use of RNA interference to investigate cytokine signal transduction in pancreatic β-cells. Methods Mol Biol 820: 179–194.
62. AllagnatF, CunhaD, MooreF, VanderwindenJM, EizirikDL, et al. (2011) Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis. Cell Death Differ 18: 328–337.
63. HeimbergH, HeremansY, JobinC, LeemansR, CardozoAK, et al. (2001) Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents beta-cell apoptosis. Diabetes 50: 2219–2224.
64. EizirikDL, Mandrup-PoulsenT (2001) A choice of death–the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44: 2115–2133.
65. EizirikDL, KutluB, RasschaertJ, DarvilleM, CardozoAK (2003) Use of microarray analysis to unveil transcription factor and gene networks contributing to β-cell dysfunction and apoptosis. Ann N Y Acad Sci 1005: 55–74.
66. CunhaDA, HekermanP, LadriereL, Bazarra-CastroA, OrtisF, et al. (2008) Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121: 2308–2318.
67. CnopM, HannaertJC, HoorensA, EizirikDL, PipeleersDG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50: 1771–1777.
68. ChenMC, ProostP, GysemansC, MathieuC, EizirikDL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44: 325–332.
69. OverberghL, ValckxD, WaerM, MathieuC (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305–312.
70. CardozoAK, KruhofferM, LeemanR, OrntoftT, EizirikDL (2001) Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50: 909–920.
71. PirotP, NaamaneN, LibertF, MagnussonNE, OrntoftTF, et al. (2007) Global profiling of genes modified by endoplasmic reticulum stress in pancreatic β-cells reveals the early degradation of insulin mRNAs. Diabetologia 50: 1006–1014.
72. EizirikDL, SandlerS, SenerA, MalaisseWJ (1988) Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 123: 1001–1007.
73. KutluB, CardozoAK, DarvilleMI, KruhofferM, MagnussonN, et al. (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52: 2701–2719.
74. HoorensA, Van de CasteeleM, KloppelG, PipeleersD (1996) Glucose promotes survival of rat pancreatic β-cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98: 1568–1574.